loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Camonsertib

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Camonsertib

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Repare Therapeutics To Present Camonsertib Data At ESMO Congress 2024
    Repare Therapeutics To Present Camonsertib Data At ESMO Congress 2024

    13 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240913906467/en

    BUSINESSWIRE
    13 Sep 2024
    Share Share
    Repare Doses First Patient In Camonsertib Non-Small Cell Lung Cancer Trial
    Repare Doses First Patient In Camonsertib Non-Small Cell Lung Cancer Trial

    10 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240610868857/en

    BUSINESSWIRE
    10 Jun 2024
    Share Share
    Repare Therapeutics: FDA Granted Fast Track For Lunresertib+Camonsertib
    Repare Therapeutics: FDA Granted Fast Track For Lunresertib+Camonsertib

    04 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240604315065/en

    BUSINESSWIRE
    04 Jun 2024
    Share Share